Clinical Practice Outcomes With Lecanemab for Alzheimer Disease. (PubMed, Neurol Open Access) - Sep 17, 2026 - "Although several markers showed modest negative predictive value, none reliably predicted ARIA. Improved markers to predict and monitor ARIA are needed to optimize cognitive outcomes."
Journal • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Hematological Disorders • APOE • Aβ42
|
|
Alexander A Moghadam; Amber Navarra; Andy J Liu; Cynthia Beam; Daniel Parker; Heather Whitson; Heba Al-Sahlani; Jeffrey R Petrella; Kim G Johnson; Laura A Wang; Michael W Lutz; Michelle Sanfilippo; Mohammad Samsul Alam; My Y Liu; P Murali Doraiswamy; Richard J O'Brien; Sandra Cobb; Sheng Luo
|